• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Animal & Veterinary

  • Print
  • Share
  • E-mail


by Karen A. Kandra
FDA Veterinarian Newsletter July/August 1999 Volume XIV, No IV

Claire M. Lathers, Ph.D., F.C.P.CVM is happy to welcome Claire M. Lathers, Ph.D., F.C.P., as the Director of CVM's Office of New Animal Drug Evaluation. Dr. Lathers comes to CVM from Barr Laboratories, Inc., Pomona, New York, where she served as the Chief Scientific Officer since 1996. In that position, Dr. Lathers was responsible for guiding the scientific development of the Research and Development Program with overall responsibility for developing clinical bioequivalence protocols and supervising the conduct of these studies at sites within the U.S. as well as internationally.

Dr. Lathers earned her Ph.D. in Pharmacology from the SUNY Buffalo Schools of Medicine and Dental Medicine. Her academic experience has included The Medical College of Pennsylvania (15 years), Albany College of Pharmacy (2 years as President, Dean, and tenured Professor); Uniformed Services University of the Health Sciences; and Gwynedd Mercy College. These academic experiences have provided extensive research, administrative, committee, and teaching opportunities.

In addition, Dr. Lathers worked for FDA's Center for Drug Evaluation and Research as a Pharmacology Reviewer for 5 years, and as a Special Government Expert for 2 years.

As a Visiting Scientist at NASA/USRA, Dr. Lathers has spent 12 years collecting data from subjects in ground-based studies and from astronauts and cosmonauts before, during and after space flight. She has achieved international recognition for her work in the two areas of cardiovascular autonomic dysfunction associated with space flight and with sudden death in persons with epilepsy. The primary focus of Dr. Lathers’ international cardiovascular pharmacology research career has centered on autonomic peripheral and central mechanisms involved in the control and regulation of blood pressure and heart rate and rhythm.

For over 15 years, Dr. Lathers taught 250 hours per year of pharmacology to medical, pharmacy, nursing, and other allied health students, introducing them to the numerous challenges of space flight and pharmacology. She developed innovative international symposia in clinical pharmacology to teach clinical pharmacology, pharmacy, and medical issues in the weightless environment of outer space and then edited the peer-reviewed articles written from these presentations for publication in 3 entire issues of the Journal of Clinical Pharmacology (May and June 1994 and October 1991).

Dr. Lathers has authored or co-authored over 300 publications, including 2 books. She is the Immediate Past-President of the American College of Clinical Pharmacology, having previously served as Regent, Treasurer, President-Elect and President. For her broad contributions to the discipline and to the College, Dr. Lathers was the recipient of the Distinguished Service Award in Clinical Pharmacology in 1997. In addition, The Board of Regents of the American College of Clinical Pharmacology confirmed her as an Honorary Regent with Life-Time Status in 1996.

Dr. Lathers looks forward to the diversity of challenges that her new CVM position holds. Her vast experience in research, academia, industry, and government makes Dr. Lathers a valuable addition to CVM's management team.